Live feed
Filing
SC 13G
SC 13G0001103804-18-000035·Eidos Therapeutics, Inc.
Schedule 13G ownership disclosure
EIDOS THERAPEUTICS INC
Security class unavailable · CUSIP: 28249H104
Event date: 2018-06-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,986,201
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001103804-18-000035
- Form type
- SC 13G
- Filer
- Eidos Therapeutics, Inc.
- CIK
- CIK 1731831
- Filed
- Jul 02, 2018
- Reporting period
- Jun 22, 2018
- Description
- Schedule 13G beneficial ownership